Author: admin

New Faith-Based Wellness Movement Counters Muscle Loss From Popular Weight Loss Drugs

Faith-based wellness coach Simbaa Akamaru, founder of the Gospel Fit Community, is raising awareness about the hidden dangers of rapid weight loss drugs like Ozempic. His message: fast weight loss can mean lost muscle, energy, and confidence—especially for women. Through faith-driven fitness, strength training, and culturally relevant nutrition, Simbaa helps people transform their bodies and lives—mind, body, and spirit.

Minneapolis, MN – Wellness coach and faith-based fitness leader Simbaa Akamaru, also known as Coach Simbaa, will officially launch the “Strength Over Skinny” campaign, a bold initiative designed to raise awareness about the overlooked risks of popular GLP-1 medications like Ozempic, Wegovy, and Mounjaro.

Backed by his Gospel Fit Community, Akamaru is addressing a growing concern: while these medications promise rapid weight loss, they are quietly contributing to muscle depletion, fatigue, and loss of body tone—especially among women.

“Rapid weight loss without intentional strength training isn’t a win,” says Akamaru. “It’s a warning. We’re losing more than just pounds—we’re losing power.”

Akamaru, a licensed trainer and founder of a faith-centered fitness movement, says these effects are not just anecdotal. They’re impacting a large number of people who feel weaker, not stronger, after drastic weight loss.

The Strength Over Skinny Campaign Will Offer:

  • Virtual and In-Person Training Plans focused on maintaining curves, strength, and definition

  • Soulful Nutrition Guidance rooted in cultural relevance and real-life accessibility

  • Faith-Based Wellness Tools to help people honor their bodies as temples

  • Workshops and Events starting June 19 to educate and empower community members

“I created this campaign because our people deserve more than quick fixes,” says Akamaru. “They deserve transformation that lasts—physically, spiritually, and mentally.”

Why It Matters

With GLP-1 medications dominating headlines, Coach Simbaa’s holistic, strength-focused solution puts the power back in people’s hands. His campaign encourages individuals to pair medical support with mindful movement, emphasizing that weight loss doesn’t have to come at the cost of wellness.

For those using or considering medications like Ozempic, Akamaru offers a vital message:

“Don’t trade your strength for a number on the scale.”

Media Contact:

Simbaa Akamaru

Email: simbaaakamaru@gmail.com

Phone: 507.990.1251

Social: @coach_simbaa

Media Contact
Company Name: SimbaaFIT Nutrition Club
Contact Person: Simbaa Akamaru
Email: Send Email
Country: United States
Website: https://www.instagram.com/coach_simbaa/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New Faith-Based Wellness Movement Counters Muscle Loss From Popular Weight Loss Drugs

Hanley Investment Group Arranges Sale of New Construction 7-Eleven in Chino, Calif., for $7.05 Million

CHINO, Calif. – Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today that the firm arranged the $7.05 million sale of a newly constructed, single-tenant property occupied by a 7-Eleven convenience store featuring a Laredo Taco Company quick-service restaurant and 12 fuel pumps in The Preserve master-planned community in Chino, California.

The transaction resulted in a 5.25% cap rate — the lowest achieved for a single-tenant 7-Eleven priced over $5 million in California in the last year, according to CoStar data.

Hanley Investment Group Executive Vice President Jeremy McChesney and Senior Associate Andrew Sprowl represented the developer and seller, Ledo Capital Group of Los Angeles. Ledo Capital Group is also developing a 133,527-square-foot industrial business park at The Preserve. The buyer, a private investor from San Diego, was represented by Adam Bloom of Lee & Associates San Diego.

“We secured an all-cash, non-exchange buyer through a broker relationship, achieving a record low cap rate of 5.25% for this type of asset. The Southern California-based buyer acquired a new, larger-format 7-Eleven in an area experiencing significant growth — highlighted by a recently completed $22 million bridge extending Limonite Avenue. In addition, the buyer can benefit from bonus depreciation tax advantages,” McChesney said.

The 5,596-square-foot 7-Eleven, built in 2023, is located at 15666 Hellman Avenue (at the signalized intersection of Hellman and Limonite avenues). The 1.15-acre property is leased on a corporate-backed, 15-year, triple-net absolute lease with 14 years remaining, featuring 10% rental increases every five years and four additional five-year renewal options with similar escalations.

The property is located in an area of rapid growth. A one-mile radius around the site experienced a 113% population increase between 2000 and 2010, with an anticipated additional growth of 2.12% by 2029. Within a three-mile radius, the population now exceeds 90,000, supported by an average household income of $175,000 and daytime employment for over 42,000 workers across more than 904 businesses.

Globally, 7‑Eleven operates 85,000 stores and generates $88 billion in annual sales, making it the world’s largest convenience store chain and a top U.S. franchise with more outlets than any other retailer or food service provider. The chain pioneered ATM services, gasoline sales and 24/7 operation in the convenience store industry.

“7‑Eleven remains a highly sought-after single‑tenant investment nationwide, thanks to its strong performance as a leading retailer and its proven resilience as an essential business. Its investment‑grade credit rating (S&P: A‑) and designation as an essential business by the Department of Homeland Security provide investors with a significant level of security and reliable cash flow – attributes that are especially appealing in the current economic climate,” McChesney said.

Hanley Investment Group has facilitated the sale of 52 7‑Eleven retail investments in the past six years.

About Ledo Capital Group

Ledo Capital Group (“LCG”) is a diversified investment company that provides strategic investment capital to operators, developers, and real estate professionals in the capitalization of opportunistic and value-add oriented projects in Southern California, Texas and other select western markets. LCG focuses on the acquisition of industrial, retail and multi-family assets through the deployment of flexible capital structures within both the LP & GP capital stack. With the capability to deliver any required expertise in the acquisition, development or repositioning of properties as well as any required asset management services, LCG partners can benefit significantly from these enhanced operational synergies. LCG raises capital through its private and institutional investors offering partners the ability to scale operations and focus on the acquisition side of the business, relying on the expertise of LCG to quickly underwrite and fund through its private capital fund. LCG’s capabilities include advisory services, where LCG may leverage its relationships and deep track record with institutional capital as a potential source of a joint venture capital. Visit: www.ledocapitalgroup.net.

About Hanley Investment Group

Celebrating 20 years, Hanley Investment Group Real Estate Advisors is a real estate brokerage and advisory services company with an over $11.7 billion transaction track record that specializes in the sale of retail properties nationwide. Our expertise, proven track record, and unwavering dedication to putting clients’ needs first set us apart in the industry. Hanley Investment Group creates value by delivering exceptional results through the use of property-specific marketing strategies, cutting-edge technology, and local market knowledge. Our nationwide relationships with investors, developers, institutions, franchisees, brokers, and 1031 exchange buyers are unparalleled in the industry, translating into maximum exposure and pricing for each property. With unmatched service, Hanley Investment Group has redefined the experience of selling retail investment properties. For more information, visit www.hanleyinvestment.com.

Media Contact
Company Name: Hanley Investment Group Real Estate Advisors
Contact Person: Jeremy McChesney, Executive Vice President
Email: Send Email
Phone: 949.585.7671
Address:3500 East Coast Highway, Suite 100
City: Corona del Mar
State: California
Country: United States
Website: https://hanleyinvestmentgroup.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hanley Investment Group Arranges Sale of New Construction 7-Eleven in Chino, Calif., for $7.05 Million

Multiple System Atrophy Market Set to Grow Substantially Through 2034, DelveInsight Projects | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro

The Key Multiple System Atrophy Companies in the market include – Teva Pharmaceutical/MODAG GmBH, H. Lundbeck A/S/Genmab, Alterity Therapeutics, Theravance Biopharma, Ionis Pharmaceuticals, Inc., Biohaven Pharmaceuticals, Lundbeck A/S, Alterity Therapeutics, Asklepios BioPharmaceutical, Inhibikase Therapeutics, RETROTOPE, Modag, AC Immune, Vaxxinity, Neuramedy, ProMIS Neurosciences, FAScinate Therapeutics, Wren Therapeutics, Blade Therapeutics, Stealth BioTherapeutics, and others .

 

DelveInsight’s “Multiple System Atrophy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Multiple System Atrophy, historical and forecasted epidemiology as well as the Multiple System Atrophy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Multiple System Atrophy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Multiple System Atrophy Market Forecast

 

Some of the key facts of the Multiple System Atrophy Market Report:

  • The Multiple System Atrophy market size was valued approximately USD 43 Million in 2023 and is anticipated to grow with a significant CAGR of 44.7% during the study period (2020-2034)

  • In February 2025, ATH434 by Alterity Therapeutics exhibited encouraging Phase 2 results in a randomized, double-blind trial for early-stage multiple system atrophy (MSA). The treatment, especially at a 50 mg dose, was well-tolerated and showed both clinical improvements and biomarker-based benefits.

  • In July 2024, Alterity Therapeutics announced promising interim results from the Phase II trial of ATH434 for Multiple System Atrophy. The analysis incorporated clinical and biomarker data from seven participants who were treated for six months, as well as neuroimaging data from three individuals who received treatment for 12 months. Remarkably, 43% of participants showed improved scores on the UMSARS Activities of Daily Living Scale after six months, indicating a decrease in disability.

  • In 2023, the U.S. MSA market was valued at approximately USD 38 million, representing 88% of the total market. This value is projected to rise substantially with the launch of new therapies.

  • In 2023, the combined market size of the EU4 and the UK was estimated at around USD 2.3 million, accounting for nearly 5% of the total market revenue across the 7MM.

  • In 2023, Germany held the largest market share among the EU4 and the UK, with an estimated value of approximately USD 0.57 million, followed by the UK at around USD 0.50 million. Spain had the smallest market share, reaching nearly USD 0.32 million.

  • In 2023, Japan’s MSA market was valued at approximately USD 2.98 million, with expectations of growth throughout the forecast period (2024–2034).

  • Estimates suggest that among the emerging therapies, Amlenetug (Lu AF82422) is projected to hold the largest market share, generating approximately USD 795 million in revenue across the 7MM by 2034.

  • DelveInsight’s estimates indicate that in 2023, there were approximately 70,800 prevalent cases of MSA across the 7MM. The U.S. accounted for 60% of these cases, while the EU4 and the UK contributed nearly 16%, and Japan represented 24%.

  • In 2023, the U.S. had the highest prevalence of MSA, with around 42,500 cases. This number is projected to grow at a CAGR of 1.0% through 2034.

  • In 2023, Germany had the highest prevalence of MSA among the EU4 and the UK, with approximately 2,700 cases, followed by the UK with around 2,400 cases. Spain reported the lowest prevalence, with nearly 1,500 cases.

  • In 2023, Japan recorded approximately 5,100 prevalent cases of MSA in males and 12,000 in females, with these numbers expected to increase by 2034.

  • In the U.S. in 2023, MSA cases were distributed as follows: approximately 400 in stage 0, 800 in stage 1, 2,100 in stage 2, 15,000 in stage 3, 13,000 in stage 4, and 10,000 in stage 5. These numbers are expected to increase by 2034

  • Key Multiple System Atrophy Companies: Teva Pharmaceutical/MODAG GmBH, H. Lundbeck A/S/Genmab, Alterity Therapeutics, Theravance Biopharma, Ionis Pharmaceuticals, Inc., Biohaven Pharmaceuticals, Lundbeck A/S, Alterity Therapeutics, Brain Neurotherapy Bio, Inc., Biogen, Corestem, Inc., Asklepios BioPharmaceutical, Inhibikase Therapeutics, RETROTOPE, Modag, AC Immune, Vaxxinity, Neuramedy, ProMIS Neurosciences, FAScinate Therapeutics, Wren Therapeutics, Blade Therapeutics, Stealth BioTherapeutics, and others

  • Key Multiple System Atrophy Therapies: Emrusolmin (TEV-56286, Anle-138b), Amlenetug (Lu AF82422), ATH434-201/-202, Lu AF82422, Ampreloxetine (TD-9855), AAV2-GDNF Gene Therapy, ION464, ATH434, Verdiperstat, TAK-341, KM-819, rasagiline mesylate, Safinamide Methanesulfonate, AZD3241, NBMI, hOMSC300, DaTSCAN™ Ioflupane, Droxidopa, and others

  • The Multiple System Atrophy epidemiology based on gender analyzed that males are most commonly affected as compare females in case of Multiple System Atrophy (MSA) in the 7MM

  • The Multiple System Atrophy market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Multiple System Atrophy pipeline products will significantly revolutionize the Multiple System Atrophy market dynamics.

 

Multiple System Atrophy Overview

Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder that affects the body’s autonomic functions, such as blood pressure, heart rate, bladder function, and digestion, as well as motor control. MSA is characterized by a combination of symptoms similar to those of Parkinson’s disease, cerebellar ataxia, and autonomic failure.

 

Get a Free sample for the Multiple System Atrophy Market Report:

https://www.delveinsight.com/report-store/multiple-system-atrophy-msa-market

 

Multiple System Atrophy Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Multiple System Atrophy Epidemiology Segmentation:

The Multiple System Atrophy market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Multiple System Atrophy

  • Prevalent Cases of Multiple System Atrophy by severity

  • Gender-specific Prevalence of Multiple System Atrophy

  • Diagnosed Cases of Episodic and Chronic Multiple System Atrophy

 

Download the report to understand which factors are driving Multiple System Atrophy epidemiology trends @ Multiple System Atrophy Epidemiology Forecast

 

Multiple System Atrophy Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Multiple System Atrophy market or expected to get launched during the study period. The analysis covers Multiple System Atrophy market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Multiple System Atrophy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Multiple System Atrophy Therapies and Key Companies

  • Emrusolmin (TEV-56286, Anle-138b): Teva Pharmaceutical/MODAG GmBH

  • Amlenetug (Lu AF82422): H. Lundbeck A/S/Genmab

  • ATH434-201/-202: Alterity Therapeutics

  • Lu AF82422: H Lundbeck A/S

  • Ampreloxetine (TD-9855): Theravance Biopharma

  • AAV2-GDNF Gene Therapy: Brain Neurotherapy Bio, Inc

  • ION464: Ionis Pharmaceuticals, Inc.

  • ATH434: Alterity Therapeutics

  • Verdiperstat: Biohaven Pharmaceuticals, Inc.

  • TAK-341: Takeda

  • KM-819: Kainos Medicine Inc.

  • rasagiline mesylate: Teva Branded Pharma

  • Safinamide Methanesulfonate: Zambon SpA

  • AZD3241: AstraZeneca

  • NBMI: EmeraMed

  • hOMSC300: Cytora Ltd.

  • DaTSCAN™ Ioflupane: GE Healthcare

  • Droxidopa: Chelsea Therapeutics

 

Discover more about therapies set to grab major Multiple System Atrophy market share @ Multiple System Atrophy Treatment Market

 

Multiple System Atrophy Market Drivers

  • Prospect for a robust pipeline

  • New Pre-clinical MoAs

  • Increase in Multiple System Atrophy research

  • Regulatory designations

 

Multiple System Atrophy Market Barriers

  • Launch of generics

  • Diagnostic barrier

  • Limited clinical research

 

Scope of the Multiple System Atrophy Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Multiple System Atrophy Companies: Teva Pharmaceutical/MODAG GmBH, H. Lundbeck A/S/Genmab, Alterity Therapeutics, Theravance Biopharma, Ionis Pharmaceuticals, Inc., Biohaven Pharmaceuticals, Lundbeck A/S, Alterity Therapeutics, Brain Neurotherapy Bio, Inc., Biogen, Corestem, Inc., Asklepios BioPharmaceutical, Inhibikase Therapeutics, RETROTOPE, Modag, AC Immune, Vaxxinity, Neuramedy, ProMIS Neurosciences, FAScinate Therapeutics, Wren Therapeutics, Blade Therapeutics, Stealth BioTherapeutics, and others

  • Key Multiple System Atrophy Therapies: Emrusolmin (TEV-56286, Anle-138b), Amlenetug (Lu AF82422), ATH434-201/-202, Lu AF82422, Ampreloxetine (TD-9855), AAV2-GDNF Gene Therapy, ION464, ATH434, Verdiperstat, TAK-341, KM-819, rasagiline mesylate, Safinamide Methanesulfonate, AZD3241, NBMI, hOMSC300, DaTSCAN™ Ioflupane, Droxidopa, and others

  • Multiple System Atrophy Therapeutic Assessment: Multiple System Atrophy current marketed and Multiple System Atrophy emerging therapies

  • Multiple System Atrophy Market Dynamics: Multiple System Atrophy market drivers and Multiple System Atrophy market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Multiple System Atrophy Unmet Needs, KOL’s views, Analyst’s views, Multiple System Atrophy Market Access and Reimbursement

 

To know more about Multiple System Atrophy companies working in the treatment market, visit @ Multiple System Atrophy Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Multiple System Atrophy Market Report Introduction

2. Executive Summary for Multiple System Atrophy

3. SWOT analysis of Multiple System Atrophy

4. Multiple System Atrophy Patient Share (%) Overview at a Glance

5. Multiple System Atrophy Market Overview at a Glance

6. Multiple System Atrophy Disease Background and Overview

7. Multiple System Atrophy Epidemiology and Patient Population

8. Country-Specific Patient Population of Multiple System Atrophy

9. Multiple System Atrophy Current Treatment and Medical Practices

10. Multiple System Atrophy Unmet Needs

11. Multiple System Atrophy Emerging Therapies

12. Multiple System Atrophy Market Outlook

13. Country-Wise Multiple System Atrophy Market Analysis (2020–2034)

14. Multiple System Atrophy Market Access and Reimbursement of Therapies

15. Multiple System Atrophy Market Drivers

16. Multiple System Atrophy Market Barriers

17. Multiple System Atrophy Appendix

18. Multiple System Atrophy Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Multiple System Atrophy Market Set to Grow Substantially Through 2034, DelveInsight Projects | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro

Osteoporosis Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medi

The Key Osteoporosis Companies in the market include – Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine, Levolta Pharmaceuticals, Inc., Celltrion, Teva Pharmaceuticals, and others.

 

DelveInsight’s “Osteoporosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Osteoporosis, historical and forecasted epidemiology as well as the Osteoporosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

The latest healthcare forecast report provides an in-depth analysis of Osteoporosis, offering comprehensive insights into the Osteoporosis revenue trends, prevalence, and treatment landscape. The report delves into key Osteoporosis statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Osteoporosis therapies. Additionally, we cover the landscape of Osteoporosis clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Osteoporosis treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Osteoporosis space.

 

To Know in detail about the Osteoporosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Osteoporosis Market Forecast

 

Some of the key facts of the Osteoporosis Market Report:

  • The Osteoporosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)

  • In March 2025, the FDA approved Fresenius Kabi Biopharma’s denosumab biosimilars, Conexxence and Bomyntra (denosumab-bnht), for all indications of the reference products Prolia and Xgeva, expanding access to more affordable treatments for osteoporosis, bone metastases, and other bone-related conditions.

  • In March 2025, Dr. Reddy’s Laboratories Ltd. and Alvotech announced that the FDA has accepted a 351(k) Biologic License Application (BLA) submission for AVT03, a proposed biosimilar of Prolia® (denosumab) and Xgeva® (denosumab), developed by Alvotech.

  • In March 2025, Celltrion announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) and OSENVELT® (CT-P41, denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab), respectively, for all indications of the reference products.

  • In November 2024, the FDA accepted the biologics license application for HLX14, a denosumab (PROLIA/XGEVA) biosimilar, from Organon and Shanghai Henlius Biotech. Denosumab is FDA-approved for treating postmenopausal women at high fracture risk, those with inadequate responses to other osteoporosis treatments, and patients on long-term corticosteroids.

  • Key Osteoporosis Companies: Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine, Levolta Pharmaceuticals, Inc., Celltrion, Teva Pharmaceuticals, and others

  • Key Osteoporosis Therapies: EVENITY (romososzumab), EB613 (PTH 1-34), RT-102, Research programme, RT-102, SHR-1222, VOLT01, CT-P41, TVB-009, and others

  • The Osteoporosis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteoporosis pipeline products will significantly revolutionize the Osteoporosis market dynamics.

  • As per the International Osteoporosis Foundation, Osteoporosis affected approximately 5.2% of the total population in the UK, closely aligning with the EU27+2 average of 5.6%. Among individuals aged 50 and above in the UK, it was estimated that 21.9% of women and 6.7% of men had Osteoporosis. Hip fractures are considered the most severe outcome of the disease due to their significant impact on health, mortality, and healthcare costs.

  • A study by Yoshimura et al. (2022) reported that in Japan, the prevalence of lumbar spine (L2–L4) osteoporosis was 13.6% at the initial survey (3.4% in men and 19.2% in women) and dropped significantly to 9.7% at the fourth survey (1.4% in men and 13.9% in women), with the difference being statistically significant (p < 0.01). However, no significant change was observed in the prevalence of femoral neck osteoporosis between the two surveys.

 

Osteoporosis Overview

Osteoporosis is a medical condition in which bones become weak, brittle, and more prone to fractures due to a loss of bone density and strength. It often develops silently over time and is most common in older adults, especially postmenopausal women. Common fracture sites include the hip, spine, and wrist. The condition can be managed or prevented through calcium and vitamin D intake, regular weight-bearing exercise, and medications that help strengthen bones.

 

Get a Free sample for the Osteoporosis Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/osteoporosis-market

 

Osteoporosis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Osteoporosis Epidemiology Segmentation:

The Osteoporosis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Osteoporosis

  • Prevalent Cases of Osteoporosis by severity

  • Gender-specific Prevalence of Osteoporosis

  • Diagnosed Cases of Episodic and Chronic Osteoporosis

 

Download the report to understand which factors are driving Osteoporosis epidemiology trends @ Osteoporosis Epidemiology Forecast

 

Osteoporosis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Osteoporosis market or expected to get launched during the study period. The analysis covers Osteoporosis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Osteoporosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Osteoporosis Therapies and Key Companies

  • EVENITY (romososzumab): Amgen and UCB

  • EB613 (PTH 1-34): EnteraBio

  • RT-102: Rani Therapeutics

  • Research programme: Lactocore

  • RT-102: Rani Therapeutics

  • SHR-1222: Jiangsu HengRui Medicine

  • VOLT01: Levolta Pharmaceuticals, Inc.

  • CT-P41: Celltrion

  • TVB-009: Teva Pharmaceuticals

 

Discover more about therapies set to grab major Osteoporosis market share @ Osteoporosis Treatment Landscape

 

Osteoporosis Market Drivers

  • Rising geriatric population prone to low bone density, growing investments in research and development, increased focus on development of biosimilars for the treatment of Osteoporosis are some of the important factors that are fueling the Osteoporosis Market.

 

Osteoporosis Market Barriers

  • However, side effects and complications associated with osteoporosis drugs, patent expiration of osteoporosis drugs and other factors are creating obstacles in the Osteoporosis Market growth.

 

Scope of the Osteoporosis Market Report

  • Study Period: 2019–2032

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Osteoporosis Companies: Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine, Levolta Pharmaceuticals, Inc., Celltrion, Teva Pharmaceuticals, and others

  • Key Osteoporosis Therapies: EVENITY (romososzumab), EB613 (PTH 1-34), RT-102, Research programme, RT-102, SHR-1222, VOLT01, CT-P41, TVB-009, and others

  • Osteoporosis Therapeutic Assessment: Osteoporosis current marketed and Osteoporosis emerging therapies

  • Osteoporosis Market Dynamics: Osteoporosis market drivers and Osteoporosis market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Osteoporosis Unmet Needs, KOL’s views, Analyst’s views, Osteoporosis Market Access and Reimbursement

 

To know more about Osteoporosis companies working in the treatment market, visit @ Osteoporosis Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Osteoporosis Market Report Introduction

2. Executive Summary for Osteoporosis

3. SWOT analysis of Osteoporosis

4. Osteoporosis Patient Share (%) Overview at a Glance

5. Osteoporosis Market Overview at a Glance

6. Osteoporosis Disease Background and Overview

7. Osteoporosis Epidemiology and Patient Population

8. Country-Specific Patient Population of Osteoporosis

9. Osteoporosis Current Treatment and Medical Practices

10. Osteoporosis Unmet Needs

11. Osteoporosis Emerging Therapies

12. Osteoporosis Market Outlook

13. Country-Wise Osteoporosis Market Analysis (2019–2032)

14. Osteoporosis Market Access and Reimbursement of Therapies

15. Osteoporosis Market Drivers

16. Osteoporosis Market Barriers

17. Osteoporosis Appendix

18. Osteoporosis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Osteoporosis Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medi

Blue Sky Scrubs Launches Limited Edition Americana Scrubs to Celebrate the 4th of July

Proudly Made in America, Designed to Inspire.

Austin, TX, USA – June 19, 2025 – This Independence Day, Blue Sky Scrubs proudly announces the launch of its Limited Edition Americana Scrubs Collection, a bold and spirited celebration of freedom, craftsmanship, and the American worker. Known for designing high-quality, fashion-forward medical apparel, Blue Sky Scrubs is once again blending patriotism with purpose—offering medical professionals a way to wear their American pride on their sleeves, quite literally.

The new Americana Scrubs are available for a limited time and feature a fresh take on classic red, white, and blue. The design is inspired by vintage Americana aesthetics and the timeless style of hardworking Americans. From subtle star-spangled patterns to clean, modern tailoring, this collection pays tribute to the frontline heroes who serve their communities every day—and to the country they serve with pride.

Made in America, From Thread to Tag

As many companies have shifted manufacturing overseas, Blue Sky Scrubs has stayed true to its roots. Every stitch of the Americana Scrubs is sewn in the United States, reinforcing the brand’s long-standing commitment to American manufacturing. From sourcing fabrics to final packaging, these scrubs are 100% made in America.

“There’s something incredibly meaningful about launching this collection around the 4th of July,” said the company’s founder. “These scrubs aren’t just clothing—they’re a symbol of quality, integrity, and the hardworking spirit that defines this country. When our customers wear Blue Sky, they’re not just wearing something stylish and comfortable—they’re supporting American jobs and American values.”

A Salute to the Healthcare Community

The Limited Edition Americana Scrubs are also a salute to the incredible resilience and dedication of healthcare professionals. In a time when the world continues to lean on doctors, nurses, and essential workers, Blue Sky Scrubs aims to recognize the tireless commitment these professionals make every day.

This collection is not just about honoring a holiday—it’s about celebrating the everyday heroes who keep our communities safe and healthy. Wearing Americana Scrubs is a small but powerful way for medical professionals to show their pride in their profession and their country.

Limited Run, Unlimited Patriotism

This year’s Americana Collection will only be available through July 31, or while supplies last. Styles are available for both men and women, featuring modern tailoring, reinforced seams, and the unmatched comfort Blue Sky is known for. Each set is embroidered with a subtle American flag detail and a commemorative 2025 tag, making them not only functional but collectible.

The Collection includes:

• The Heritage Top & Classic Pant in navy with red stitching

• The Liberty Jogger with star accents

• The Independence Slim-Fit Top in white with navy trim

• Custom embroidered scrub caps with stars and stripes options

• Quantities are limited, and early orders are encouraged to ensure availability.

Supporting American Jobs

As part of the launch, Blue Sky Scrubs is highlighting the faces behind the product—real American workers who cut, sew, and package the scrubs in facilities across the country. In doing so, the brand is putting a spotlight on the importance of buying American-made and investing in domestic manufacturing.

“For us, it’s more than a marketing angle. It’s a business philosophy,” said the company. “We’re proud that our scrubs are made in the USA. Our customers care about where their products come from, and they want to support companies that do business the right way.”

More Than Just Scrubs

Blue Sky Scrubs isn’t just selling apparel—they’re building community. Over the years, the company has built a loyal following among medical professionals who appreciate thoughtful design, long-lasting quality, and the personal touches that come with every order.

With the Americana Collection, Blue Sky Scrubs continues to lead the way in healthcare fashion, while doubling down on its values: quality, responsibility, and American pride.

Red, White, and You

Whether you’re working in a hospital, a dental office, a lab, or volunteering in your community this summer, Blue Sky’s Americana Scrubs let you wear your pride with purpose. They’re designed to move with you, breathe with you, and represent you—because comfort and confidence should never be mutually exclusive.

This 4th of July, wear something that stands for something. Choose scrubs that support American workers. Choose Blue Sky Scrubs.

Availability:

The Limited Edition Americana Collection is available exclusively at www.blueskyscrubs.com while supplies last.

About Blue Sky Scrubs

Founded in Austin, Texas, Blue Sky Scrubs has been redefining medical apparel since 2005. Known for premium fabrics, tailored fits, and a commitment to American-made quality, Blue Sky is trusted by thousands of healthcare professionals across the country. From scrubs to lab coats to scrub caps and beyond, every piece is designed with integrity, durability, and comfort in mind.

Learn more at www.blueskyscrubs.com.

Media Contact
Company Name: Blue Sky Scrubs
Contact Person: Azu Aguilera
Email: Send Email
Phone: 888-302-5837
Country: United States
Website: https://blueskyscrubs.com

Concordia shanghai Breaks Ground on Visionary New Rittmann Center

State-of-the-art facility will transform student life through the arts, athletics, and wellness.

Shanghai, China – June 19, 2025 – Concordia International School Shanghai is set to break ground on a major redevelopment of the Rittmann Center, expanding the iconic facility into a modern, 13,710-square-meter multi-purpose hub designed to support student excellence in academics, the arts, athletics, and wellness.

Named after former Head of School Dr. David Rittmann, the Rittmann Center was first completed in December 2007, with a purpose to enhance the school’s creative arts education.

More than five times the size of the current building, the new Rittmann Center marks one of the largest facility investments in the school’s history. Designed to serve students across all divisions, it embodies Concordia’s commitment to innovation, sustainability, and holistic education.

image.png

The new center will house:

· An eight-lane, 25-meter competition pool with spectator seating for 240

· A professional-grade theater with seating for over 500—a major upgrade from the current 330

· Purpose-built music classrooms for band, choir, and strings

· Six dedicated practice rooms, three ensemble rooms, and a 170m² drama studio

· Four expansive art studios filled with natural light and designed for creative exploration

· Two underground floors and four above ground, maximizing space while maintaining a compact campus footprint

· A green roof and infrastructure built to meet LEED II certification standards, continuing the school’s focus on sustainability

image.png

Architects from Ennead have worked closely with the school to shape a building that’s not only functional but inspiring, incorporating advanced acoustic treatments, energy-efficient HVAC systems, and student-centered design principles to support 21st-century learning and performance.

“The Rittmann Center has long been a space where students shine,” said Dr. Eric Semler, Head of School. “This new facility will take that to the next level—empowering students to explore their passions, build confidence, and thrive in a community that celebrates their talents.”

Construction will begin after the end of the 2024–25 school year and is expected to be completed by July 2027. To minimize disruption to learning, the school has implemented:

· Phased construction scheduling tied to school breaks

· Sound barriers, vibration dampeners, and dust suppression systems

· Dedicated traffic flow systems to avoid student movement areas

“This is more than a building project – it’s an investment in our students’ future. It’s about creating an environment where future generations can learn, perform, and grow,” added Dr. Semler.

About Concordia International School Shanghai

Founded in 1998, Concordia International School Shanghai is a co-educational day school that offers a comprehensive American-style education to students from Preschool through High School. Located in Jinqiao, an international community in Shanghai’s Pudong New Area, we are dedicated to cultivating the unique gifts of our students in any areas they are passionate about. We are known for our commitment to educational excellence and for providing well-developed sports, fine arts, service, and applied learning programs. Our approach focuses on nurturing every student through a journey of personal and academic growth, offering innovative academic programs, enriching extracurricular activities, and instilling strong character and values. We are dedicated to helping each student achieve a bright and prosperous future of personal excellence.

Media Contact
Company Name: Concordia International School Shanghai
Contact Person: Brandon Fisher, Joan Wu
Email: Send Email
City: Shanghai
Country: China
Website: https://www.concordiashanghai.org/

Guizhou’s Village BA Debuts on NBA’s Stage

At the NBA’s Chinese New Year celebration in 2025, held at Barclays Center in Brooklyn, a handmade cotton basketball from a remote village in Guizhou, China, captured the spotlight. This modest symbol of grassroots sports marked the first official cultural exchange between Guizhou’s Village BA and professional basketball in the United States.

https://youtu.be/Vn2OxtUqc6M?si=ep2KKLzPxXiz4YfY

A Handmade Ball’s Journey Across the Ocean

Eighty-three-year-old Lu Dajiang, a villager from Taipan, proudly showcased a cotton basketball passed down through his family. “My brother made this in the 1950s out of cotton. We used it for games back then,” he recalled. Though unassuming in appearance, the ball embodies the legacy of Village BA. In the 1950s, faced with a lack of resources, basketball enthusiasts in rural Guizhou crafted their own balls from cotton. This handmade ball has since borne witness to the birth and rise of the Village BA tradition.

The Spirit of the Soil on the Streets of New York

Village BA may have started in the countryside, but its influence now reaches far beyond the mountains. Today, it resonates with basketball fans around the world, especially among overseas Chinese youth eager to experience its unfiltered energy.

With no grand arenas or professional gear, Village BA thrives on pure passion for basketball and the villagers’ dreams of a better life—becoming a cultural emblem of rural China.

A Moment of Cultural Exchange on the NBA Stage

At the NBA’s Chinese New Year celebration, the cotton basketball was passed through the crowd, hand to hand. This cotton basketball opened a new window into China’s rural sports culture. With Village BA gaining global traction, its story as a cultural export is only just beginning.

Media Contact
Company Name: Guizhou Radio TV Station
Contact Person: Chen Xin
Email: Send Email
Country: China
Website: http://www.gzstv.com

Best tips to prevent cholesterol this summer

Best tips to prevent cholesterol this summer

It is common to relax good lifestyle habits in summer, a mistake we should not make in the field of health and wellness. If you want to prevent cholesterol and enjoy good health, these tips and recommendations will help you avoid hypercholesterolemia and its possible consequences.

Watch your diet to avoid high cholesterol

To prevent cholesterol, it is essential to follow a healthy diet. It is as necessary to limit or, better yet, avoid consuming foods that can raise LDL cholesterol as it is to eat foods that raise HDL cholesterol levels.

Thus, it is advisable to avoid the consumption of alcoholic beverages, especially those of high alcohol content. Precooked foods rich in saturated fats, pastries and cakes, cheeses and fried foods should also be avoided. In addition, it is preferable to limit the consumption of cheese and fatty sausages.

On the other hand, this summer it will be good for you to control your cholesterol by enjoying a diet rich in fresh fruits and vegetables, adding legumes to salads, as well as eating raw and unsalted nuts and dried fruits in moderate quantities, but on a daily basis. It is also important to consume oily fish and whole grains.

Taking dietary supplements to prevent cholesterol and triglycerides

Natural substances such as reishi, safflower fruit oil or omegas 3, 6 and 9 help to control blood cholesterol levels. They are easy to take in the form of food supplements.

At Robis we have a selection of dietary supplements for cholesterol to take as a support to take care of your cardiovascular health and prevent problems. Solutions such as Reishi Robis, Garcinia Complex or Red Yeast Rice Complex are suitable for people with LDL cholesterol levels close to the limit considered healthy and people with hypercholesterolemia.

As an example, red yeast contains monacolin K, a natural substance that inhibits a key enzyme for cholesterol production in the liver, HMG-CoA reductase. Omega-3, omega-6 and omega-9 fatty acids increase “good” cholesterol and reduce “bad” cholesterol and triglycerides, as well as prevent plaque buildup in the arteries. And Garcinia suppresses the accumulation of LDL cholesterol and triglycerides in the blood vessels.

Consult your doctor about the convenience of taking supplements to help prevent cholesterol and listen to his or her advice to improve your overall health.

Physical exercise to prevent hypercholesterolemia

Physical exercise helps keep cholesterol in check by helping to maintain a healthy body weight. Exercise increases the body’s levels of the so-called good cholesterol, HDL cholesterol, which is key to reducing the bad or LDL cholesterol.

Summer is a great opportunity to enjoy exercise as a leisure activity and acquire good habits to take care of your health and well-being all year round. If you like to go to the beach or the pool, take the opportunity to swim. Walking at a brisk pace and hiking is also good exercise to prevent cholesterol, as is dancing or cycling.

It’s also a good time to have fun with team sports or gentle jogging outdoors in clean air. In addition, in many resort areas there are parks with bio-healthy circuits for exercise, not only oriented to seniors.

Avoid smoking to prevent cholesterol

If you smoke, quit as soon as possible. You probably already know that it is a harmful habit for your health. In the case of cholesterol, smoking increases blood pressure and affects blood circulation.

Whether or not you are a smoker, as far as possible, avoid becoming a passive smoker.

Increase physical activity in your daily life

In addition to physical exercise, it is advisable to lead a more active and less sedentary life. On a daily basis, try to move more. You can go up and down stairs from time to time instead of using the elevator or take up a hobby that requires physical movement.

Media Contact
Company Name: Robis
Contact Person: Press Office
Email: Send Email
Country: United States
Website: https://robis.es/atributo/solucion/cholesterol-triglycerides/

Kitchen Remodeling in Houston: Trusted by Homeowners, KR Masters Emerges as the Destination for High-ROI Renovations

Kitchen Remodeling in Houston: Trusted by Homeowners, KR Masters Emerges as the Destination for High-ROI Renovations
Houston’s veteran-owned Kitchen Remodel Masters delivers high-ROI kitchen remodels with custom 3D designs, premium materials, and faster turnarounds, earning a 99% five-star referral rate.

A trusted name in the remodeling industry, Kitchen Remodel Masters Houston stands out for its expert design and meticulous craftsmanship, ensuring homeowners a seamless kitchen remodeling experience while delivering high-quality, exquisitely refined kitchens built to last.

What distinguishes Kitchen Remodel Masters Houston in the competitive kitchen renovation market is its comprehensive, turnkey approach. Each project begins with a personalized consultation, involving an in-house interior designer who guides clients through layout planning, style selection, and material choices. This hands-on support ensures a cohesive, stress-free renovation process from start to finish.

Founded by his father, Kitchen Remodel Masters Houston is presently helmed by Sean Carmel, who continues the legacy of this veteran and family-operated business. With over 20 years of experience, the company is certified, licensed, and committed to excellence in every project it undertakes.

Kitchen Remodel Masters Houston has a reputation for completing projects faster than industry averages without compromising quality. Supported by an experienced team of craftsmen, a dedicated project manager oversees every phase, employing a streamlined process to coordinate and maintain strict timelines and quality control. Unlike many competitors, the company fabricates its cabinets and stone countertops in-house, guaranteeing top-tier quality and precision.

For more information, visit https://krmasters.com/ or Kitchen Remodel Masters Houston.

“Our team of skilled professionals specializes in home remodeling, kitchen remodeling, and custom cabinet services, making us one of the best kitchen remodeling companies in Houston. With a 99% five-star referral rate, efficient project management, and flexible financing options, we deliver strong ROI and faster turnaround times than industry averages,” said Carmel.

Kitchen Remodel Masters Houston helps homeowners optimize layouts for functionality and style, ensuring every inch of space is utilized efficiently. Custom 3D design plans allow clients to visualize their new kitchen before construction begins. The company also prioritizes sustainability and health, using premium materials such as low-VOC cabinets for safer spaces and durable stone countertops to ensure longer-lasting kitchens.

“As a family-owned business, we prioritize customer service. Let us help you design your dream kitchen with free quotes and 15% off for veterans and seniors. Our mission is simply to deliver stunning kitchens with zero shortcuts. From design to final cleanup, we treat every home like it’s our own,” added Carmel.

As full turnkey kitchen and bathroom remodeling experts, Kitchen Remodel Masters Houston delivers affordable yet stylish cabinetry tailored for the modern home. Renowned for its unmatched customer service, clients can expect transparent communication and flexible financing options, making high-end renovations more accessible to the market.

Each project involves an interior designer who works closely with the client, helping them with layout, style, finishes, and material selection to bring their ideas to life in a free 3D floor plan. Skilled experts at Kitchen Remodel Masters Houston bring the design to life with precision, maintaining excellent standards throughout the process to ensure the project is completed on time and within budget.

After construction, the team performs a thorough quality check and makes the necessary adjustments before handover. Clients can expect the remodeled kitchen or bathroom to match their unique style while maximizing functionality.

For Houston residents planning a kitchen renovation, Kitchen Remodel Masters Houston offers trusted solutions that combine innovation, quality, and unmatched service. With a reputation for speed, efficiency, and reliability, the company delivers renovations that maximize home value, focusing on durable materials, functional layouts, and aesthetic appeal to ensure clients enjoy immediate satisfaction and long-term benefits.

About the Kitchen Remodel Masters Houston:

Based in Houston, TX, Kitchen Remodel Masters Houston is a veteran-owned kitchen remodeling company specializing in premium kitchen remodeling and bathroom renovations. The company is trusted for its fast turnaround, high-quality renovations, and exceptional customer satisfaction, boasting custom 3D design visualizations, in-house cabinetry, countertop fabrication, and low-VOC materials to ensure high-quality, sustainable upgrades.

Media Contact
Company Name: Kitchen Remodel Masters Houston
Contact Person: Seam Carmel
Email: Send Email
Phone: (713) 364-6603
Address:1923 Washington Ave Ste 2036
City: Houston
State: TX 77007
Country: United States
Website: https://krmasters.com/

Le James Venue to Open in 2026, Bringing Elegant Wedding and Event Space to Downtown Charleston

Charleston’s historic French Quarter to welcome a new wedding and corporate event venue blending 19th-century architecture with modern design.

A new addition to Charleston’s hospitality scene is on the way as Le James Venue prepares to open its doors in early 2026. Located at 35 Prioleau Street in the heart of the city’s French Quarter, the venue will serve as a premier Charleston wedding and event venue. Combining preserved 19th-century architecture with updated features suited for modern events, Le James is sure to impress the Charleston Hospitality community.

Set within a three-story, 25,000-square-foot building dating back to the 1850s, Le James is being developed by the McIntyre Family of Business. The family acquired the property following the Harbor Club’s relocation and is now overseeing its transformation into a fully restored, five-star wedding and corporate event venue. The project highlights Charleston’s architectural legacy while supporting its continued growth as a destination for luxury weddings and business functions.

Designed to host weddings, milestone occasions, and professional gatherings, Le James is expected to attract interest from clients across the country. The venue will feature a 3,000-square-foot rooftop terrace with views of the Cooper River, a formal ballroom, a glass-ceiling dining and entertainment space, and a vintage-style bar inspired by New York City’s Polo Bar. Interiors are being developed in collaboration with Charleston design studio Fritz Porter.

“This isn’t just a building restoration—it’s an investment in the future of Charleston as a destination for meaningful celebrations,” said a spokesperson for the venue and director of operations. “Le James will offer a flexible, elegant, and fully immersive experience for those seeking a Charleston wedding venue or a distinctive corporate event venue that honors the spirit of the city.”

Alongside its architectural features, Le James will offer amenities designed to meet the needs of modern hosts. The venue includes dedicated suites for wedding parties, boardrooms for business events, and curated vendor partnerships to support a range of services, including planning, florals, and entertainment. Though weddings will remain the primary focus, the space will also welcome corporate events, galas, and community functions that align with its standards and capacity.

Charleston tourism and economic development leaders anticipate the venue’s launch will strengthen the downtown economy and further elevate the city’s profile in the events and hospitality sector. With Charleston routinely ranked among the top wedding destinations in the United States, Le James is projected to generate year-round interest from couples and event professionals, with a likely increase in activity for surrounding businesses in lodging, dining, and retail.

The building’s history reflects Charleston’s evolution. Originally constructed as one of four warehouse structures known as “Napier’s Range” during the city’s mercantile boom, the structure at 35 Prioleau Street survived the 1886 earthquake and was later used as a furniture storage site, private club, and restaurant. Its upcoming renovation maintains original features such as brick masonry, arches, and exposed tie beams—offering a blend of preservation and utility.

“This building has witnessed every phase of Charleston’s growth—from colonial trade to contemporary celebrations,” the spokesperson said. “With Le James, we’re not erasing that legacy. We’re elevating it for the next generation.”

Once complete, Le James Venue will support a team of full-time staff, including event coordinators and service personnel. Additional seasonal hiring is planned closer to the 2026 opening. Initial private tours are scheduled to begin in late 2025, with official bookings for weddings and corporate events opening next year. Interested parties can submit inquiries via email at reservation@lejamesvenue.com.

Positioned near The Pineapple Fountain and within walking distance of South Carolina’s only five-star hotel, the venue offers a central location for both local and out-of-town guests. Its walkability, historic charm, and customizable design have already drawn the attention of several national wedding planners and event venue professionals seeking refined options in Charleston.

The venue’s reuse of an iconic structure has also garnered positive feedback from preservation groups and Charleston residents, many of whom see the project as a model of responsible development. Le James contributes to local heritage efforts while offering a practical solution for Charleston’s growing event needs.

In a city where tradition and transformation continue to intersect, Le James Venue represents the next step in Charleston’s commitment to elegance, hospitality, and historical continuity.

About Le James Venue

Le James Venue is an upcoming wedding venue and event venue located in downtown Charleston, South Carolina, opening in 2026. The venue is housed in a restored 19th-century building at 35 Prioleau Street and is designed to host weddings, corporate events, and private celebrations. With features including a rooftop terrace, formal ballroom, and vintage-style bar, Le James merges historical architecture with modern design.

As a dedicated Charleston wedding venue, Le James emphasizes personalized service, curated vendor partnerships, and immersive experiences. The venue also accommodates corporate event venue bookings and select community functions. For more information or to inquire about booking, visit lejamesvenue.com.

Media Contact
Company Name: Le James Venue
Contact Person: Codi Mcintyre
Email: Send Email
Country: United States
Website: https://lejamesvenue.com/